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Abstract
Background: Assessing the liver function provides valuable information to evaluate surgical risk and plan
accordingly. Current studies focus on whole liver function evaluation. However, assessment of segmental liver
function is equally important in the clinical practice. The purpose of this study was to investigate whether Gd-EOB-
DTPA-enhanced MRI can evaluate the liver function of each segment by using T1 mapping at 3 Tesla MRI.
Methods: One hundred three patients were classified into one of 4 groups: a normal liver function (NLF) group (n = 38),
a liver cirrhosis with Child-Pugh A (LCA) group (n = 33), a liver cirrhosis with Child-Pugh B (LCB) group (n = 21), and a liver
cirrhosis with Child-Pugh C (LCC) group (n = 11). All patients underwent Gd-EOB-DTPA-enhanced MRI scans. T1 relaxation
times were measured on the liver superimposing T1 mapping images. Reduction rate (△%) of T1 relaxation time of the
liver parenchyma were calculated.
Results: After 20 min of Gd-EOB-DTPA enhancement, the T1 relaxation time of all liver segments in the LCC group were
different from those in all the other groups, and more liver segments from the LCB and LCA groups different from the
NLF group (p < 0.05). For the LCB group, the areas under the receiver operating characteristic curves (AUCs) of different
liver segments for hepatobiliary phase (HBP) were 0.654-0.904 on T1 relaxation time, and 0.709-0.905 on △%. For the LCC
group, the AUCs of different liver segments for HBP were 0.842–0.997 on T1 relaxation time, and 0.887–0.990 on △%.
Conclusions: For LCB patients, segmental liver function evaluation is possible using Gd-EOB-DTPA-enhanced MRI T1
mapping. For LCC patients, all liver segments can be used to evaluate liver function and both T1 relaxation time and the
△% of T1 relaxation time have good diagnostic performance.
Keywords: Gd-EOB-DTPA, T1 mapping, Liver function, MRI
Background
Liver function assessment plays a significant role in clinical
practice, especially for surgeons predicting future remnant
liver function after partial hepatectomy. Assessing the func-
tion of each segment of liver provides valuable information
to evaluate surgical risk and plan accordingly.
In recent years, using MRI to evaluate liver function
became possible with the clinical application of liver
specific MRI contrast agents. Gadolinium ethoxybenzyl
diethylenetriamine penta-acetic acid (Gd-EOB-DTPA)
has recently come into use to assess liver lesions and
function [1–5]. Gd-EOB-DTPA can be injected as an
intravenous bolus and provides enhanced MRI phase in-
formation as an MRI non-specific gadolinium contrast.
After 20 min, approximately 50% of the administered
dose is transported into the hepatocytes and gets eventu-
ally excreted into the bile in normal functioning human
livers [6–8]. Gd-EOB-DTPA clearance depends on the in-
tegrity of the hepatocytes, and decreased liver function
leads to a decreased liver uptake of Gd-EOB-DTPA.
Previous studies have shown the feasibility of using
Gd-EOB-DTPA enhanced MRI to predict liver function by
measuring liver parenchymal or biliary tract enhancement
on hepatobiliary-phase (HBP) MR imaging, or by
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calculation of the liver/spleen signal contrast ratio [9–12].
However, MR signal intensity is not an absolute value
and there exists a non-linear relationship with the
gadolinium concentration. Moreover, MRI signal
intensity also varies at different time points due to
MRI technical factors, such as radiofrenquency ampli-
fication, receiver coil and sequences designed by dif-
ferent MRI systems [13, 14]. On the other hand, the
T1 relaxation time is an absolute value, and in theory, it is
directly related to the concentration of Gd-EOB-DTPA
in the body. It can be directly measured on MRI T1
mapping and used for comparison between different
acquisition times.
The Child-Pugh classification has been one of the
most used means to estimate total liver function in the
clinic. It consists of five clinical features and is used to
evaluate the prognosis of chronic liver disease and cir-
rhosis [15, 16]. A study by Katsube in 2011 was the first
one evaluating T1 mapping on Gd-EOB-DTPA-en-
hanced MRI to assess liver function [17], its results
showed that post-contrast T1 relaxation times were sig-
nificantly extended in cases of abnormal liver function
compared to the shorter T1 relaxation times in normal
livers. The 18-min time-point was deemed best to evalu-
ate liver function. Other researchers have also shown
correlations between the T1 relaxation time at the liver
parenchyma and the liver function [18–23].
Current studies focus on whole liver function evalu-
ation. However, assessment of segmental liver function
is equally important in the clinical practice. The purpose
of this study was to investigate whether Gd-EOB-DTPA-
enhanced MRI can evaluate the liver function of each
segment by using T1 mapping at 3 Tesla MRI.
Methods
Patients
This study was designed as a prospective study that
included 103 consecutively enrolled patients who under-
went GD-EOB-DTPA-enhanced MRI examination, at The
First Affiliated Hospital of Guangxi Medical University
and Affiliated Hospital of Guilin Medical University, from
October 2014 to December 2015. This study was ap-
proved by the ethics committees of the First Affiliated
Hospital of Guangxi Medical University and the Affiliated
Hospital of Guilin Medical University. All patients signed
informed consents before the contrast agent was injected.
The inclusion criteria consisted of the following: (1)
patients with available clinical examination and biochem-
ical tests that can be classified as a Child-Pugh score. (2)
Absence of a liver resection surgery, radiofrequency abla-
tion, chemotherapy or liver embolization procedure. (3)
Absence of biliary obstruction or diffuse liver diseases
caused by biliary tract disease. (4) The size of lesions was
smaller than the segment which lesion existed.
As a result, 103 patients (82 men and 21 women, with
a mean age of 54.2 ± 13.2 years) were included in the
study. All patients were classified into one of 4 groups: a
normal liver function (NLF) group (n = 38), a liver cir-
rhosis with Child-Pugh A (LCA) group (n = 33), a liver
cirrhosis with Child-Pugh B (LCB) group (n = 21), and a
liver cirrhosis with Child-Pugh C (LCC) group (n = 11);
The characteristics of the patients in each group are
shown in Table 1. For the groups comprised of patients
with focal liver lesions, the size of the lesions had no
effect on the T1 relaxation time measurements.









Age (years) 53.9 ± 15.1 49.0 ± 13.3 55.2 ± 9.0 52.5 ± 12.4
Total bilirubin (umol/l) 15.7 ± 6.9 16.1 ± 7.4 48.4 ± 27.3 86.6 ± 21.2
Serum albumin (g/l) 42.3 ± 5.1 40.6 ± 4.2 33.5 ± 5.2 29.0 ± 3.5
Prothrombin time (INR) 1.05 ± 0.23 1.03 ± 0.23 1.22 ± 0.34 1.48 ± 0.59
Values =mean ± stardard deviation
Fig. 1 T1 relaxation measurement of liver segments, 1a: 1 ROI measurement in S1 segment;1b:3 ROI measurement in each liver segment
Zhou et al. BMC Medical Imaging  (2017) 17:20 Page 2 of 7
MRI
All patients underwent unenhanced and enhanced MRI
scans (10 mL Gd-EOB-DTPA at 0.25 mmol/mL,
Germany Bayer Healthcare Co.) using a Siemens Verio
3.0 T MRI scanner with a 12-channel body phased-array
coil. Images were obtained with HASTE, TSE T2WI
axial free breathing with fat suppression, EPI DWI axial
breath hold with fat suppression, T1WI VIBE axial fat
suppression plain and enhanced scanning. The Gd-EOB-
DTPA was administered as a bolus, which was injected
at a rate of 2 mL/s through the cubital vein; this was
followed by a 20 mL saline chaser, which was adminis-
tered at the same rate. For all patients, T1WI VIBE with
syngo MapIt included: repetition time (TR) 3.9 ms, echo
time (TE) 1.4 ms, flip angle 5° and 15°,field of view
(FOV) 273 × 380 mm, Matrix 161X320 mm, 3 mm sec-
tion thickness, and parallel imaging technique (P = 2)
with generalized auto-calibrating partially parallel acqui-
sition (GAPPA), performed for T1 mapping on pre-
enhanced, 5, 10 and 20 min delay phases after GD-EOB-
DTPA administration.
Imaging analysis
All the obtained data were transferred to a Siemens syngo
workstation to measure T1 relaxation times using operator-
defined regions of interest (ROIs). The ROI with a 2.15 cm2
Fig. 2 T1 relaxation time of each liver segment at different Gd-EOB-DTPA-enhanced MRI phases: 2a:T1 relaxation times in liver segments were no
significantly different between groups before enhancement. 2b: After 5 min Gd-EOB-DTPA enhancement, the T1 relaxation times of the liver segments
in the LCB and LCA groups were different from those in the NLF and LCA group (p < 0.05). 2c: After 10 min Gd-EOB-DTPA enhancement, T1 relaxation
times of liver segments in LCB, and of all the segments in LCA were different from those in NLF and LCA group (p < 0.05). 2d: After 20 min Gd-EOB-
DTPA enhancement, the T1 relaxation times in all LCA segments were different from the segments in the other groups, more liver segments in the
LCB group were different from those in the NLF and LCA group (p < 0.05)
Table 2 One-Way Anova LSD test (significance level = 0.05) was used to compare the average T1rt on each liver segment for the
four groups, the time points include pre-enhancement, 5, 10 and 20 min after GD-EOB-DTPA enhanced MRI
S1 S2 S3 S4 S5 S6 S7 S8
Pre p 0.575 0.382 0.533 0.915 0.492 0.684 0.103 0.284
F 0.666 1.032 0.736 0.172 0.808 0.498 2.116 1.285
5 min p 0.000 0.044 0.132 0.001 0.000 0.000 0.000 0.004
F 9.010 2.789 1.917 6.323 7.869 10.287 16.486 4.748
10 min p 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
F 30.346 17.093 30.957 19.911 36.363 28.984 26.679 20.271
20 min p 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
F 30.960 34.918 63.449 38.156 38.245 38.883 35.003 42.828
Pre: Pre-enhancement; 5 min, 10 min and 20 min: the time point of post-enhancement, p value less than 0.05 was considered statistically significant; F: the ratio
value of F test
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(140–180 pixels) area was drawn manually on the liver
superimposing T1 mapping images. Three ROIs were
identified from the segment at the edge of the liver to the
central liver segments S2-S8, one ROI was identified on
liver segment S1, without focal lesions, major branches of
portal or hepatic veins, or imaging artifacts. In addition, the
rate of T1 relaxation time between pre-enhanced and post-
enhanced phase at each time point was calculated using the
following equation: Reduction rate (△%) = (T1pre-T1 post)
×100/T1pre, where T1pre and T1post were the T1 relaxation
time of the liver segment before and after GD-EOB-DTPA
administration (Fig. 1 and Additional file 1).
Statistical analysis
The statistical analysis was performed using the SPSS
20.0 software package. Descriptive statistics (mean ±
standard deviation) were provided when appropriate.
The One-Way Anova least significant difference (LSD)
analysis of variance was used to compare the differences
in T1 relaxation time of liver segment for each group
with the same segment. Receiver operating characteristic
(ROC) curves were used to determine the diagnostic
performance of T1 relaxation time and △% of T1 relax-
ation time for liver function. Corresponding areas under
the ROC curve, sensitivities and specificities were calcu-
lated with 95% confidence interval (CI), the best cut-off
value was predicted by the Maximum Youden-Index:
Sensitivity + Specificity - 1. Any difference with a p value
less than 0.05 was considered statistically significant.
Results
T1 relaxation time of each liver segment at different time
points
The T1 relaxation times for each liver segment decreased
gradually in the NLF and LCA groups from 5 min to
20 min after Gd-EOB-DTPA administration. The average
T1 relaxation times at 20 min imaging delay ranged from
125.4 to 212.5 ms in the NLF group and from 138.4 to
228.2 ms in the LCA group. The T1 relaxation times for
each liver segment varied unpredictably in the LCB and
LCC groups from one time point to the next (5 to 20 min
after the Gd-EOB-DTPA enhancement). The average T1
relaxation times at 20 min imaging delay ranged from
152.3 to 363.1 ms in the LCB group and from 315.6 to
485.4 ms in the LCC group (Additional file 2).
The T1 relaxation times in different segments of liver
were not significantly different between groups before
enhancement. After 5 min of Gd-EOB-DTPA enhance-
ment, the T1 relaxation times in some segments started
to differ, particularly most segments in the LCC group
started to show markedly different T1 relaxation times
than the liver segments of the other groups (p < 0.05).
After 10 min of Gd-EOB-DTPA enhancement, more T1
relaxation times of liver segment became different
among groups, some segments in the LCB group and all
in the LCC group were significantly different from those
in the NLF and LCA groups (p < 0.05). Finally, after
20 min of Gd-EOB-DTPA enhancement, the T1 relax-
ation time of all liver segments in the LCC group were
different from those in all the other groups, and more
Table 3 One-Way Anova LSD test (significance level = 0.05) was used to compare the average △% of T1rt on each liver segment for
the four groups, the time points include 5, 10 and 20 min after GD-EOB-DTPA enhanced MRI
S1 S2 S3 S4 S5 S6 S7 S8
5 min P 0.000 0.148 0.397 0.001 0.000 0.000 0.000 0.001
F 14.539 1.820 0.999 17.813 15.366 20.433 25.336 5.992
10 min P 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
F 30.070 18.218 30.019 32.019 57.027 24.752 40.254 17.071
20 min P 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
F 31.490 37.797 54.010 44.451 52.427 36.159 42.761 36.332
Pre: Pre-enhancement; 5 min, 10 min and 20 min: the time point of post-enhancement, p value less than 0.05 was considered statistically significant; F: the ratio
value of F test
Table 4 Diagnostic performance of T1rt at HBP for assessing LCB group segment function by receiver operating characteristic (ROC)
analysis
S1 S2 S3 S4 S5 S6 S7 S8
AUC 0.836 0.654 0.727 0.810 0.836 0.904 0.852 0.771
95% CI 0.75–0.92 0.52–0.78 0.63–0.83 0.71–0.91 0.75–0.92 0.84–0.96 0.77–0.93 0.67–0.87
Cut-offs: 238.0 143.7 132.1 148.5 228.1 233.1 215.9 130.1
Sensitivity 90.5% 71.4% 90.5% 81.0% 71.4% 100% 90.5% 100%
Specificity 71.2% 71.2% 61.6% 75.3% 83.6% 78.1% 75.3% 46.6%
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liver segments from the LCB and LCA groups different
from the NLF group (p < 0.05) (Fig. 2). The statistical re-
sults of T1 relaxation times of different liver segments
among groups were provided in Table 2. The statistical
results of the △% of T1 relaxation times of different liver
segments among groups were provided in Table 3.
Diagnostic performance of liver segment function
assessment
The ROC curves of LCB and LCC groups were used to
compare the diagnostic performance of T1 relaxation
time and △% of T1 relaxation time for assessment of
liver segment function. The corresponding sensitivity,
specificity and best cut-off value were calculated. For the
LCB group, different liver segments showed different
diagnostic performances (Table 4 and Table 5). However,
all liver segments consistently showed good diagnostic
performance in the LCC group (Table 6 and Table 7).
Discussion
For patients requiring a liver resection, the conventional
evaluation method has included a clinical liver function
exam combined with a liver volume assessment to evalu-
ate the future remnant liver function after partial hepatec-
tomy. Based on CT scan and liver volume measurements,
researchers reported that the hepatocyte volume per unit
of body weight was significantly correlated with indocya-
nine green (ICG) clearance test results and other parame-
ters of normal liver function [24]. Others also reported
that the ICG-parameters were in proportional relationship
with hepatic parenchymal cell volume [25]. Those reports
regarded the liver as a homogeneous organ. However, yet
other studies showed pathological evidence for differences
between different liver regions [26–28]. The lessons from
all those preliminary studies made it clear that an assess-
ment of segmental liver function is a necessary approach
for most patients, and that estimation of whole liver func-
tion may not be accurate.
To the best of our knowledge, no study has yet reported
the evaluation of liver segments function by using T1 re-
laxation time with Gd-EOB-DTPA-enhanced MRI. In our
study, we measured T1 relaxation time and calculated the
△% of T1 relaxation time for each liver segment. The best
diagnostic value of T1 relaxation time at HBP was from
250.8 to 376.7 ms for the LCC group and from 130.1 to
238.0 ms for the LCB group. The best diagnostic value of
△% of T1 relaxation time at HBP was from 40.6% to 55.5%
for the LCC group and from 47.9 to 70.7% for the LCB
group. The mechanism of the different T1 relaxation
times in different liver segments is not clear. In our study,
the △% of T1 relaxation time was calculated for reducing
the impact of the differences of the pre-enhancement liver
T1 relaxation times in different segments. However, differ-
ences in the △% of the T1 relaxation time were still found
in each segment. Our results showed that the changing
trends of the T1 relaxation time and the △% of T1 relax-
ation time were similar in all segments. However, the
value of each segment was quite different. Different liver
segments had different diagnostic values. A single value
may not be good enough to evaluate both whole liver
function and segmental liver function.
The diagnostic value of the T1 relaxation times found
in research publications differ from one to another. Kat-
sube et al. [17] reported that the cut-off value of T1 re-
laxation time at 18 min after Gd-EOB-DTPA injection,
to distinguish LCB from other groups with best accuracy
is less than 520 ms at HBP. On the other hand, Haimerl
et al. [20] reported that the cut-off to differentiate LCB
Table 5 Diagnostic performance for △% of T1rt at HBP for evaluating LCB group segment function by receiver operating
characteristic (ROC) analyses
S1 S2 S3 S4 S5 S6 S7 S8
AUC 0.870 0.709 0.738 0.818 0.889 0.856 0.905 0.850
95% CI 0.99–0.94 0.58–0.84 0.63–0.85 0.72–0.92 0.81–0.96 0.78–0.93 0.84–0.97 0.76–0.94
Cut-offs: 63.9% 66.8% 70.7% 64.8% 47.9% 67.7% 37.1% 50.0%
Sensitivity 75.3% 63.0% 42.5% 71.2% 97.3% 63% 98.6% 94.5%
Specificity 100% 85.7% 95.2% 90.5% 66.7% 100% 71.4% 71.4%
Table 6 Diagnostic performance of T1rt at HBP for assessing LCC group segment function by receiver operating characteristic (ROC)
analyses
S1 S2 S3 S4 S5 S6 S7 S8
AUC 0.912 0.969 0.997 0.972 0.966 0.918 0.842 0.990
95% CI 0.79–1.00 0.93–1.00 0.99–1.00 0.93–1.00 0.93–1.00 0.86–0.98 0.89–0.99 0.97–1.00
Cut-offs: 376.7 250.8 239.4 276.1 306.9 322.3 306.9 236.1
Sensitivity 81.8% 90.9% 100% 90.9% 100% 100% 100% 100%
Specificity 95.7% 96.8% 96.8% 97.9% 93.6% 79.8% 86.2% 90.4%
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from LCA was 329.5 ms. Yet, Ding et al. [18] reported
that the HBP T1 relaxation time was equal to the △% of
T1 relaxation time, and the results showed the post-
contrast value of T1 relaxation time to be 292.3 ±
59.2 ms for poor liver function and 217.3 ± 52.9 ms for
good liver function. Those reports showed significant
differences in terms of the diagnostic value of T1 relax-
ation time for evaluation of liver function.
In our study, the diagnostic performance of T1 relax-
ation time and the reduction of T1 relaxation time differ
in the different groups. For the LCC group, the AUC of
diagnosis performance was above 0.9 for both T1 relax-
ation time and the △% of T1 relaxation time, but exclud-
ing the S7 (AUC = 0.84) measurement for T1 relaxation
time at HBP. All liver segments showed a significant
good performance of diagnosis for HCC patients. For
the LCB group, the AUC of diagnostic performance for
S6 and S7 measurement of T1 relaxation time were over
0.85, others segments have lower diagnostic performance
AUC from 0.654 to 0.836. The results showed that for
LCB patients, the three best segments for determining
the diagnosis were S5, S6 and S7. S1 showed a similar
diagnostic performance to that of S5. However, the size
of S1 is much smaller than others liver segments, thus it
is not a good option for making diagnostic measure-
ment. The △% of T1 relaxation time measurement at
HBP showed improved AUCs in each segment, except in
the AUC of S6 that was reduced from 0.904 to 0.856.
Our results showed that the △% of T1 relaxation time
improved the diagnostic performance at HBP. Further-
more, the diagnostic value of T1 relaxation time has
shown significant variation among different previous re-
ports, but the diagnostic value of the △% of T1 relax-
ation time has shown variation only within a small
range. So, we suggest that the △% of T1 relaxation time
may be more efficient for evaluation of liver function.
Our study has several limitations. First, we only used
the Child-Pugh score to classify liver function and assign
patients to each group; no pathological proofs or ICG
tests were included, so the liver function in each patient
could differ markedly. Second, all patients were injected
with the same dose of Gd-EOB-DTPA, no correlation
between the dose and body weight may be a source of
variation. Third, the results showed the difference of T1
relaxation time and the △% of T1 relaxation time in each
liver segment after Gd-EOB-DTPA administration, al-
though a correlation of T1 relaxation time and liver
function at HBP was reported previously, we did not
find any direct evidence that the T1 relaxation time in
the HBP matched the real segmental liver function. Fur-
ther studies are required.
Conclusions
For LCB patients, segmental liver function evaluation is
possible by using Gd-EOB-DTPA-enhanced MRI T1
mapping, and calculation of the △% of T1 relaxation
time may be more efficient for evaluation of segmental
liver function. For LCC patients, all liver segments can
be used to evaluate liver function and both T1 relaxation
time and the △% of T1 relaxation time have good diag-
nostic performance.
Additional files
Additional file 1: Measurement of T1 relaxation time in all groups. A-D:
measurement of T1 relaxation time in NLF group (A-D), LCB group (E-H)
and LCC group (I-L), all images were obtained from pre-enhancement
(A,E,I) 5 min (B,F,J), 10 min (C,G,K) and 20 min (D,H,L) after Gd-EOB-DTPA
administration. The averages of T1 relaxation time were as follows:
630.2 ms (A), 225.0 ms (B), 166.6 ms (C), 160.1 ms (D), 846.0 ms (E),
314.7 ms (F), 248.7 ms (G), 226.3 ms (H), 504.5 ms (I), 246.5 ms (J),
273.4 ms (K), 288.5 ms (L). The reduction of T1 relaxation times at 5 min,
10 min and 20 min post-enhancement were 64.3%, 73.6% and 74.6% in
NLF, 51.3%, 61.5 and 65.0% in LCB, and 51.1%, 45.8% and 42.8% in LCC,
respectively. (PDF 1198 kb)
Additional file 2: The value of the T1 relaxation time and the
percentage of △% of T1 relaxation time cross the all segment on
pre- and post-enhancement T1 mapping in all groups. Additional table 1
showed that the value of the T1 relaxation time (ms) (Mean ± SD) cross
the all segment on pre- and post-enhancement T1 mapping in all
groups. Additional table 2 showed that the percentage of % of T1
relaxation time (%) (Mean ± SD) cross the all segment on pre- and
post-enhancement T1 mapping in all groups. (PDF 270 kb)
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